Investors Need to Consider the Medical Marijuana Industry Regardless of Interest Rates

For investors looking for an industry unaffected by changing interest rates, shares of Canopy Growth Corp. (TSX:WEED) may provide a lot of insight.

| More on:

Last week, the increase in the overnight rate put forth by the Bank of Canada dominated the news. Although there are a lot of positives that have come out of this decision, there are also still many negatives that will be felt down the road.

For investors looking for an opportunity to invest in an industry that will be little affected by the changes in interest rates, the medical marijuana industry may be it.

Although investors have traditionally viewed the technology industry as the go-to industry during periods of rising interest rates, it is important to realize that companies that are the main pillars of the industry have started to take on more debt as the businesses have become more sustainable amid technological changes.

Given this, the medical marijuana industry, which is in its infancy stages, may just be an investor’s best bet.

Beginning with Canada’s largest competitor by market capitalization, Canopy Growth Corp (TSX:WEED), which trades at slightly less than $8 per share, carries only $8 million dollars of long-term debt. As of March 31 of this year, there is more than $100 million in cash on the balance sheet.

Investors need not worry. If anything, the company has a substantial amount of cash in the bank and may just be receiving a return for the money sitting in short-term investments or a savings account. The full $100 million would not all be sitting in a checking account.

Next on the list is Aurora Cannabis Inc. (TSXV:ACB), which at $2.36 per share carries a market capitalization of more than $850 million. The company is currently carrying close to $18 million in debt with cash and cash equivalents of almost $115 million. Clearly, the solvency of this company is not a concern at this point.

The third major medical marijuana company, which became public only very recently, is MedReleaf Corp. (TSX:LEAF). In spite of having only $6 million in debt obligations, it may still be an investor’s best bet.

The company has only $12 million in cash on the balance sheet and is the only competitor that is cash flow positive. When investors consider the cash flow statement, the total cash flows from operations for the years ended March 31, 2017, was positive $12.1 million and positive $1.4 million for the previous year.

Given the rapid growth of the medical marijuana industry, which is slated to become the “marijuana industry” in less than one year, investors may have found an expanding business and a place to hide should rates continue in the upward direction.

Although it may be a little too early to decide if these companies fit into the defensive or the cyclical categories, investors can rest assured that in either case, these companies will only be impacted in a very small way if interest rates continue to climb.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Goldsman has no position in any stocks mentioned.

More on Investing

money cash dividends
Stocks for Beginners

Have $500? 3 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now

If you're looking for cheap stocks, these three have a huge future ahead of them, all while costing far less…

Read more »

edit Woman in skates works on laptop
Dividend Stocks

3 No-Brainer Stocks to Buy Under $30

These three stocks all offer a huge deal for investors looking for dividends, as well as growth that will last.

Read more »

Business man on stock market financial trade indicator background.
Tech Stocks

1 Growth Stock Down 50 Percent to Buy Right Now

There are plenty of growth stocks in the market worth considering, but Shopify (TSX:SHOP) looks like one of the best…

Read more »

You Should Know This
Dividend Stocks

How to Convert a $300 Monthly Investment Into $338 in Monthly Income

If you want a certain amount in monthly passive income, invest a similar amount today and leave the rest to…

Read more »

Increasing yield
Dividend Stocks

3 Income Stocks With Big Yields to Consider in April 2024

If you haven’t yet made your March investments, here are three income stocks to buy the dip and lock in…

Read more »

Senior Man Sitting On Sofa At Home With Pet Labrador Dog
Dividend Stocks

RRSP Investors: Don’t Miss Out on This Contribution Hack!

This hack has so many benefits for you -- not just when you put it in your RRSP but for…

Read more »

edit Sale sign, value, discount
Stocks for Beginners

These 3 Growth Stocks Are on Sale and Set to Surge

Some growth stocks are on sale right now that offer massive long-term potential for investors. Here's a trio to consider…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »